FILGRASTIM | B103353 | AMGEN
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 7-Year Orphan | Mar. 30, 2022 | Expired | Purple Book |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12371728(manufacturing) · relevance 65/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
Top 50 of 101 AI-discovered patents by relevance.
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| D. Del. | 2020-04-24 | Terminated 2021-09-08 | — | |
| CASD | 2019-07-23 | Terminated 2019-12-20 | — | |
| CAND | 2019-02-21 | Terminated 2019-05-14 | — | |
| D. Del. | 2018-07-18 | Terminated 2021-09-08 | — | |
| D.N.J. | 2018-03-08 | Terminated 2019-11-25 | — | |
| CAND | 2014-10-24 | Terminated 2018-01-08 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.